Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Brain Neoplasms 206Glioblastoma 169Central Nervous System Neoplasms 138Astrocytoma 135Gliosarcoma 132Neuroblastoma 109Glioma 104Oligodendroglioma 87Medulloblastoma 68Sarcoma 51Neoplasms 45Ependymoma 43Osteosarcoma 40Wilms Tumor 39Familial ependymoma 38Neuroectodermal Tumors, Primitive, Peripheral 36Optic Nerve Glioma 33Breast Neoplasms 33Lymphoma, Non-Hodgkin 32Neurofibromatosis 1 31Choroid Plexus Neoplasms 29Lymphoma 28Burkitt Lymphoma 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Rhabdomyosarcoma 23Rhabdoid Tumor 23Recurrence 21Meningioma 21Carcinoma, Non-Small-Cell Lung 21Testicular Neoplasms 20

Interventions

Vincristine 1Methotrexate 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Ototoxicity × CNS × Clear all
NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡